Physical Activity and Physical Fitness in Children and Adolescents Diagnosed With Sickle Cell Disease: A Scoping

Ariane Levesque1, Deepika Pugalenthi Saravanan1, Peri Newman1

  • 1Department of Pediatrics, Division of Hematology and Oncology, Penn State Health Children's Hospital, Hershey, PA, USA (AL, DPS, PN, SD, GMS, MC).

Insights

Physical activity (PA) assessments and interventions for children with sickle cell disease (SCD) are inconsistent and limited. More research is needed to develop specific PA guidelines for this population.

Area of Science:

  • Pediatrics
  • Hematology
  • Sports Medicine

Background:

  • Physical activity (PA) benefits for children with sickle cell disease (SCD) are not well-established.
  • Existing research presents a divided view on the advantages of PA for this demographic.

Purpose of the Study:

  • To systematically review and describe PA and physical fitness assessments in children with SCD.
  • To detail current PA interventions implemented in this population.
  • To document any adverse events associated with PA interventions in children with SCD.

Main Methods:

  • A comprehensive scoping review of studies involving children (≤21 years) diagnosed with SCD.
  • Searches were conducted across major databases: MEDLINE, Embase, Cochrane, Web of Science, and PEDro.
  • Inclusion criteria required studies to assess PA, physical fitness, or include a PA intervention.

Main Results:

  • Out of 45 included studies, only 28.9% assessed PA, primarily using self-reported questionnaires.
  • A high proportion of studies (88.9%) utilized physical fitness assessments, with the 6-minute walk test being most common.
  • PA interventions were described in only two studies, with one reported adverse event.

Conclusions:

  • Current methods for assessing PA and physical fitness in pediatric SCD patients are heterogeneous.
  • There is a significant limitation in the availability and scope of PA interventions for children with SCD.
  • Future research should focus on addressing these gaps to establish evidence-based PA guidelines tailored for children with SCD.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...